🇯🇵 Japan Country × Condition
solid tumors Clinical Trials in Japan
Active clinical trials for solid tumors with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT05471856 Phase 1
Recruiting
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
Enrollment
66 pts
Country
🇯🇵 Japan
Boehringer Ingelheim
View Trial → NCT07159126 Phase 1
Recruiting
A Study of DS3610a in Participants With Advanced Solid Tumor
Enrollment
70 pts
Country
🇯🇵 Japan
Daiichi Sankyo
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in Japan?
There are currently 2 active clinical trials for solid tumors with sites in Japan, of which 2 are actively recruiting patients.
How can I join a solid tumors clinical trial in Japan?
To join a solid tumors clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in Japan?
Active solid tumors trials in Japan span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology